Results for tag: "Jaundice"

Jaundice is a yellow discoloration of the skin and eyes caused by an accumulation of bilirubin in the body. It is a common symptom of many liver diseases, including hepatitis, cirrhosis, and biliary obstruction. Treatment of jaundice depends on the underlying cause, and may include medications, lifestyle changes, and surgery. The jaundice market within the context of hepatology is a rapidly growing sector of the healthcare industry. It is driven by the increasing prevalence of liver diseases, as well as the development of new treatments and technologies. Companies in this market are focused on developing and marketing products and services to diagnose, treat, and manage jaundice and other liver diseases. These include pharmaceuticals, diagnostics, medical devices, and digital health solutions. Some of the major companies in the jaundice market include AbbVie, Gilead Sciences, Merck & Co., Novartis, Pfizer, and Roche. Other notable players include Amgen, AstraZeneca, Bristol-Myers Squibb, and Johnson & Johnson. Show Less Read more